Adequate endometrial preparation with exogenous steroids is mandatory for successful ovum donation. This study was undertaken to assess the value of endometrial thickness by ultrasound and serum oestradiol as predictors of ovum donation outcome and to analyse the correlation between serum oestradiol concentrations and the endometrial thickness. Endometrial thickness and serum oestradiol concentrations on the day of oocyte donation were recorded and compared to several in-vitro fertilization parameters. The cycles (n ⍧ 465) were classified according to serum oestradiol values and endometrial thickness. Comparison of the groups showed that endometrial thickness was significantly (P ⍧ 0.002) higher when serum oestradiol was >400 pg/ml as compared to <100 pg/ml. Pregnancy and implantation rates did not differ among the groups, women with serum oestradiol <50 pg/ml having similar outcome to the remaining cases. Endometrial thickness showed a similar picture in terms of pregnancy and implantation. Also, women with an endometrium <4 mm in size had normal pregnancy and implantation rates. There was a positive correlation (P ⍧ 0.0044) between endometrial thickness and implantation, as well as between endometrial thickness and serum oestradiol (P ⍧ 0.0184). None of the parameters examined was able to predict ovum donation outcome. It is concluded that endometrial thickness is preferred to serum oestradiol for the monitoring of endometrial development, although neither is able to predict success in oocyte donation.
Introduction
Oocyte donation is a successful method for the treatment of infertility, with accumulated birth rates Ͼ90% (Remohí et al., 1997) which compares favourably to that observed in natural cycles (Zinaman et al., 1996) . Appropriate endometrial preparation with exogenous steroids as well as the replacement of goodquality embryos are pivotal events differentiating between successful and unsuccessful cycles. For this reason, efforts have been made to assure adequate endometrial priming with oestrogens. In fact, ovarian steroid replacement protocols have been developed from the beginning with the aim to mimic as closely as possible the ovarian steroid profile throughout a normal 28 day ovulatory cycle (Lutjen et al., 1984; Navot et al., 1986) . Simultaneously, non-invasive methods of evaluation in order to assure appropriate endometrial maturation, such as endometrial biopsies in a preparatory cycle (Navot et al., 1986; Navot et al., 1989; Remohí et al., 1993) or the ultrasonographic appearance of the endometrium (Shapiro et al., 1993; Hofmann et al., 1996) have been developed.
The elegant clinical designs performed by Navot et al. (1989 Navot et al. ( , 1991 indicated that 5 days of oestrogen exposure provide sufficient stimulation for endometrial proliferation and induction of progesterone receptors to sustain normal pregnancies to term. However, these studies also showed that women treated with the so-called short protocol of oestrogen priming (5-10 days) before progesterone administration had lower serum oestradiol (oestradiol) concentrations and higher rate of early pregnancy loss (Navot et al., 1991) . Therefore, the clinical experience showed that attainment of 'normal' oestradiol concentrations for a late proliferative phase of a natural cycle was not only recommended, but also mandatory in ovum donation.
Although the measurement of endometrial thickness is an easy technique to perform, there is no agreement as to whether its determination by ultrasound is a useful parameter to predict uterine responsiveness to oestrogens. Whereas some authors have shown a relationship between a favourable endometrial thickness and a successful transfer of embryos resulting from donated oocytes (Shapiro et al., 1993; Abdalla et al., 1994) , others have failed to find such a correlation (Alam et al., 1993; Coulam et al., 1994) . Moreover, the correlation between serum oestradiol and endometrial thickness is controversial (Alam et al., 1993) . With the above information in mind, the present study was undertaken to address two issues: (i) to assess the value of both serum oestradiol concentrations and endometrial thickness, as predictors of ovum donation outcome; and (ii) to analyse the correlation between serum oestradiol concentrations and endometrial thickness in women undergoing ovum donation.
Materials and methods

Patients
Data from all oocyte donation cycles performed between January 1, 1993 and December 31, 1996 were obtained from a computer database. A total of 812 recipients undergoing 1142 embryo transfers was analysed. The total number of initiated cycles during this period was 1388; 166 were cancelled because of spotting, and 80 cycles had no embryo transfer because of total fertilization failure. Our cancellation rate was 17.3%, similar to what has been previously described (Remohí et al., 1995) . Four hundred and sixty-five cycles (408 patients) were selected because patients had had their serum oestradiol concentrations adequately measured prior to oocyte donation, and 151 (134 patients) of those also had endometrial thickness measured. Women in whom oestradiol measurements were performed outside our laboratories or whose endometrial scans were not accurately recorded were excluded from the study. Indications for oocyte donation in the 465 cycles under study were: low response to gonadotrophin stimulation (n ϭ 243 cycles; 52.3%); failure to conceive after ജ4 in-vitro fertilization (IVF) cycles (n ϭ 60; 12.9%); natural menopause (n ϭ 33; 7.1%); premature ovarian failure (n ϭ 85; 18.3%); severe endometriosis (n ϭ 28; 6.0%); or the presence of genetically-heritable diseases (n ϭ 16; 3.4%).
Donors were 129 women undergoing IVF and 124 young fertile women who voluntarily donated oocytes. Mean age of the donors was 27.9 Ϯ 0.3 and the cause of infertility in those undergoing therapeutic IVF was as follows: male infertility (n ϭ 77; 59.7%), polycystic ovaries (n ϭ 15; 11.6%), tubal infertility (n ϭ 11; 8.5%), unexplained infertility (n ϭ 22; 17.1%) and endometriosis (n ϭ 4; 3.1%). There was no difference among the established groups of recipients (age and reason for undergoing ovum donation) in the distribution of donors' oocytes. The Spanish Law for Assisted Conception requires anonymity and gratuity for ovum donation. Similarly, age must be limited to 18-35 years, and donors must have been previously tested for human immunodeficiency virus, cytomegalovirus, syphilis and hepatitis, with no personal or familial history of congenital malformation or hereditary diseases. All donors signed a written agreement. The protocol for ovarian stimulation, ovum retrieval and gamete handling in the IVF laboratory have been described elsewhere (Pellicer et al., 1989) .
Protocols for recipients
The protocol of steroid replacement for recipients has also been previously described (Remohí et al., 1995) . Briefly, patients with ovarian function were desensitized with daily s.c. administration of 1 mg leuprolide acetate (LA) (Procrin; Abbott S.A., Madrid, Spain) and began treatment in the secretory phase of the previous cycle. Hormonal replacement started on day 1 of the cycle with administration of oestradiol valerate (oestradiol valerate, Progynova; Schering Spain, Madrid, Spain) 2 mg/day on days 1-8; 4 mg/day on days 9-11; and 6 mg/day from day 12 onwards. After 13 days of oestradiol valerate administration, recipients were considered to be ready for oocyte donation, and waited until oocytes became available (Remohí et al., 1995) . On the day of oocyte donation, blood was obtained for serum oestradiol determination before the ingestion of the first daily dose of oestradiol valerate, and endometrial thickness was measured in the plane through the central longitudinal axis of the uterus using a vaginal probe (Sonoline SL-400; Siemens, Erlangen, Germany).
On the day of recovery of donated oocytes, 800 mg/day of natural micronized progesterone (Progeffik; Laboratorios Effik, Madrid, Spain) was vaginally administered to the recipient. Embryo transfer was performed 48 h after oocyte recovery using the vaginal route. After transfer, the same regimen of exogenous steroid replacement was maintained for 15 days. Thereafter, a urinary b-human chorionic gonadotrophin analysis was performed. If the result was positive, steroid administration was maintained at the same dosage until day 80 of pregnancy. Only ultrasound-documented pregnancies were considered for the purposes of the study.
Five groups of recipient cycles were defined according to the 2272 serum oestradiol concentration on the day in which progesterone administration commenced. Similarly, four groups were defined according to endometrial thickness.
Statistical analysis
Data are expressed as mean Ϯ SEM. For statistical comparison between groups, c 2 test and analysis of variance (ANOVA) were applied. Tukey's, Bonferroni's and Scheffé's tests were used to distinguish among between when ANOVA showed significant differences. In addition, linear regression and discriminant analysis were used to evaluate the correlation between several variables. P Ͻ 0.05 was considered statistically significant. The analysis was carried out using the Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA). Table I shows the results of ovum donation in the five groups of recipients classified according to serum oestradiol concentrations the day of ovum donation. These results demonstrate an equal distribution of recipients concerning age and indication for ovum donation. There was no difference among groups in the number of days women received unopposed oestradiol valerate administration before donation became available. Endometrial thickness in 151 cycles in which this measurement was available is also shown in Table I . There was a significant (P ϭ 0.002) increase in endometrial growth in women with serum oestradiol concentrations Ͼ400 pg/ml as compared to patients with oestradiol Ͻ100 pg/ml. Table I also includes the data from the IVF cycle. There was no significant difference among the groups in terms of fertilization, embryos transferred, pregnancy, implantation and miscarriage rates. The outcome of the 26 cycles with serum oestradiol Ͻ100 pg/ml was further explored by descriptive analysis. In two cycles oestrogen was Ͻ25 pg/ml; in nine it was between 25 and 50 pg/ml; in five cycles it was between 51 and 75; and in 10 cases it was 75-99 pg/ml. Overall pregnancy rates were respectively 50.0, 55.6, 20.0 and 50.0% in these four groups of cycles. Similarly, implantation rates in these cycles were respectively 25.0, 18.3, 5.0 and 7.8%.
Results
Endometrial thickness data are shown in Table II . Women were divided into four groups, between which no difference in age and reason for entering the ovum donation programme was detected. Table II also shows serum oestradiol concentrations and the results of the IVF cycle, in which no difference between groups was observed for any of the parameters tested. The outcome of the 15 cycles with endometrial thickness Ͻ7 mm was further explored. In two cycles endometrial thickness was Ͻ4 mm; in three cycles it was between 5 and 6 mm; and in the remaining 10 cycles it ranged between 6 and 6.9 mm. Pregnancy rates were respectively 50.0, 0 and 60.0%. Similarly, implantation rates in these cycles were 16.7, 0 and 16.8%.
Subsequently, we evaluated the prognostic value of serum oestradiol and endometrial thickness by using two more exact statistical methods. First, linear regression was applied. As the upper panel in Figure 1 shows, there was no correlation between serum oestradiol concentrations and the ability of an embryo to implant. A positive (P ϭ 0.0044) correlation was found between endometrial thickness and implantation, although it only explained 5% of the variance (r 2 ϭ 0.05). Finally, the correlation between both predictors of oestrogen priming was determined. The lower panel in Figure 1 shows the linear regression between serum oestradiol and endometrial thickness in which a weak, albeit positive (P ϭ 0.0184), correlation was found. We investigated the chances of pregnancy according to the parameters tested by means of discriminant analysis (Table  III) . This technique of multivariate analysis allows the classification of a series of values or subjects as a function of a number of independent variables. Neither endometrial thickness nor serum oestradiol was able to predict the occurrence of pregnancy following oocyte donation. A similar analysis was performed for the prediction of miscarriage using the same variables (Table IV) , resulting in comparable conclusions.
Discussion
The present study was undertaken to evaluate the role of serum oestradiol concentrations and/or endometrial thickness determined by ultrasound, as predictors of uterine receptivity following ovum donation in order to find valuable parameters to improve pregnancy rates. Previous clinical experience showed that shorter and lower protocols of oestradiol priming of the endometrium lead to higher miscarriage rates, indicating that there must be a certain degree of optimal endometrial proliferation enabling an appropriate appearance of progesterone receptors and the subsequent transformation into a endometrium receptive to human embryos (Navot et al., 1991) . In addition, a group of patients have been identified who systematically display thin endometria in natural cycles that 2274 may or may not respond to controlled ovarian stimulation (Sher et al., 1991) and/or exogenous oestrogens (Glissant et al., 1985) . Those women who do not respond to oestrogens in subsequent cycles perform less well following embryo replacement (Hassan and Saleh, 1996) . Thus, identification of unresponsive endometria is of crucial importance. We initially analysed serum oestradiol concentrations as a marker of uterine receptivity. The data suggested that serum oestradiol concentrations Ͻ100 pg/ml are able to induce changes sufficient to sustain normal implantation, and therefore the use of serum oestradiol concentrations to monitor adequate endometrial priming is insufficient. When those cycles with serum oestradiol Ͻ100 pg/ml were further explored, we found normal implantation at concentrations Ͻ50 pg/ml, which in natural cycles is considered to be the limit for ovarian arrest when a gonadotrophin releasing hormone analogue is employed (Pellicer et al., 1989) .
The second parameter evaluated was endometrial thickness. Several ultrasonographic markers of endometrial receptivity have been recently introduced, especially following the development of vaginal probes and Doppler technology. Endometrial thickness (Check et al., 1991; Check et al., 1993; Shapiro et al., 1993; Alam et al., 1993; Abdalla et al., 1994; Coulam et al., 1994; Bustillo et al., 1995) , the ultrasonographic pattern of the endometrium (Check et al., 1993; Coulman et al., 1994; Bustillo et al., 1995) , and an appropriate vascular fluxometry (Coulam et al., 1994; Bustillo et al., 1995) have been extensively employed to predict implantation in oocyte donation programmes as well as in IVF and other related techniques (Friedler et al., 1996) , with different results. A cut-off thickness of 7 mm is usually considered as appropriate for implantation in ovum donation (Shapiro et al., 1993; Abdalla et al., 1994; Friedler et al., 1996) . While some authors have been able to show a relationship between a favourable endometrial thickness determined by ultrasound and a successful transfer of embryos resulting from donated oocytes (Shapiro et al., 1993; Abdalla et al., 1994) , others have failed to find such a correlation (Alam et al., 1993; Coulam et al., 1994) . The same is true for the ultrasonographic pattern of the endometrial layers. Some authors have observed a correlation with pregnancy (Coulam et al., 1994; Bustillo et al., 1995) while others have not (Check et al., 1993) . In the present study we used endometrial thickness to predict endometrial receptivity. Again, we were unable to find a correlation between the ultrasonographic appearance of the endometrium and the ability of the embryos to implant. When those cycles with endometrial thickness Ͻ7 mm were further explored, we found that Ͻ4 mm yielded implantation rates comparable to that shown in Table II . This is in contrast with the observations of Abdalla et al. (1994) , who found no pregnancies when the endometrial thickness was Ͻ5 mm.
Our next step was to evaluate the correlation between serum oestradiol concentrations and endometrial thickness. Previous studies using the same model of artificial cycles for ovum donation found no such correlation in 68 individuals tested (Alam et al., 1993) . Our data showed that there was a positive, albeit weak, correlation between markers, indicating that the ultrasonographic endometrial growth is dependent on the serum oestradiol concentrations reached. In fact, Table I also showed that women with serum oestradiol Ͼ400 pg/ml had a significantly thicker endometrium than patients with serum oestradiol Ͻ100 pg/ml.
Both markers of endometrial development were combined in order to search for valid clinical conclusions, i.e. the possibility of predicting implantation and miscarriage. Linear regression between serum oestradiol and implantation showed no correlation between both parameters. However, there was a significant positive correlation between endometrial thickness and implantation.
We finally explored the prediction of pregnancy by the parameters tested using discriminant analysis. This statistical approach allows a correlation to be determined between continuous and nominal variables, similar to the linear regression of continuous variables. Once a correlation between variables is found, then the test attempts to predict the value of this variable. Discriminant analysis showed that neither of the parameters tested, serum oestradiol or endometrial thickness, was a good predictor of ovum donation outcome. In other words, there was a weak, although significant, correlation between endometrial thickness and implantation which 2275 explained only 5% of the variance (r 2 ϭ 0.05) and was not supported by discriminant analysis. This means that, even if there is a relationship between the parameters, we are unable to predict implantation and miscarriage based on a given thickness of the endometrium.
The crucial role of steroid hormones in preparing and maintaining the endometrium for successful embryonic implantation is beyond any doubt. However, unlike progesterone, oestradiol requirements for implantation in humans are very low. The majority of authors appear to agree with the concept that oestradiol is permissive but not essential in mammals that do not undergo dispause (Ghosh et al., 1994; Ghosh and Sengupta, 1995; Edgar, 1995; de Ziegler, 1995) . This clinical study suggests the existence of a wide oestradiol window which allows the endometrium to prepare itself for implantation. The window reported herein also reflects a permissive hormonal effect rather than a direct action performed at the paracrine/autocrine concentration by cytokines and adhesion molecules (Simón et al., 1996) . This may be the reason for the absence of a relationship between oestradiol concentrations and implantation at the clinical concentration.
Taken together, these findings show that neither serum oestradiol nor endometrial thickness is able to predict implantation. Thus, neither can be clinically employed to cancel a cycle because of insufficient endometrial preparation. However, there is a positive correlation between endometrial thickness and implantation that must be kept in mind. Based on this observation, we feel that endometrial thickness is more relevant than serum oestradiol in terms of monitoring, and that this parameter should be employed to fix the dose of oestradiol valerate in each particular case in order to obtain a sufficient endometrial development. However, it is important to emphasize that there is no reason for cancellation whatever the endometrial thickness determined by ultrasound.
